Financial Counselors Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,048
Closed -$1.22M 79
2025
Q1
$1.22M Buy
12,048
+4,680
+64% +$472K 0.02% 314
2024
Q4
$658K Sell
7,368
-1,664
-18% -$149K 0.01% 380
2024
Q3
$757K Buy
9,032
+30
+0.3% +$2.51K 0.01% 376
2024
Q2
$693K Sell
9,002
-100
-1% -$7.7K 0.01% 361
2024
Q1
$623K Sell
9,102
-60
-0.7% -$4.11K 0.01% 382
2023
Q4
$530K Buy
9,162
+381
+4% +$22K 0.01% 395
2023
Q3
$464K Buy
8,781
+3
+0% +$158 0.01% 402
2023
Q2
$475K Sell
8,778
-203
-2% -$11K 0.01% 362
2023
Q1
$449K Buy
8,981
+117
+1% +$5.85K 0.01% 369
2022
Q4
$410K Sell
8,864
-332
-4% -$15.4K 0.01% 387
2022
Q3
$356K Sell
9,196
-39
-0.4% -$1.51K 0.01% 389
2022
Q2
$344K Sell
9,235
-1,071
-10% -$39.9K 0.01% 406
2022
Q1
$456K Buy
10,306
+873
+9% +$38.6K 0.01% 370
2021
Q4
$401K Sell
9,433
-919
-9% -$39.1K 0.01% 385
2021
Q3
$449K Buy
10,352
+39
+0.4% +$1.69K 0.01% 387
2021
Q2
$441K Sell
10,313
-992
-9% -$42.4K 0.01% 386
2021
Q1
$437K Sell
11,305
-275
-2% -$10.6K 0.01% 380
2020
Q4
$416K Buy
11,580
+102
+0.9% +$3.66K 0.01% 385
2020
Q3
$439K Sell
11,478
-5,993
-34% -$229K 0.01% 353
2020
Q2
$613K Buy
17,471
+6,358
+57% +$223K 0.02% 344
2020
Q1
$363K Buy
11,113
+304
+3% +$9.93K 0.02% 341
2019
Q4
$489K Sell
10,809
-50
-0.5% -$2.26K 0.02% 352
2019
Q3
$442K Hold
10,859
0.02% 356
2019
Q2
$467K Hold
10,859
0.02% 343
2019
Q1
$417K Buy
10,859
+3,867
+55% +$148K 0.02% 349
2018
Q4
$247K Sell
6,992
-125
-2% -$4.42K 0.01% 397
2018
Q3
$274K Sell
7,117
-199
-3% -$7.66K 0.01% 418
2018
Q2
$239K Sell
7,316
-200
-3% -$6.53K 0.01% 440
2018
Q1
$205K Buy
+7,516
New +$205K 0.01% 449
2017
Q4
Sell
-7,816
Closed -$228K 484
2017
Q3
$228K Buy
7,816
+278
+4% +$8.11K 0.01% 441
2017
Q2
$209K Buy
+7,538
New +$209K 0.01% 456
2014
Q2
Sell
-10,848
Closed -$147K 424
2014
Q1
$147K Buy
+10,848
New +$147K 0.01% 420